Brief: Orchard Therapeutics Sees Its Cash, Cash Equivalents And Marketable Securities As Of Dec. 31, 2019 Will Enable Co To Fund Itself Into H1 Of 2021
13/01/2020 12:17
Jan 13 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS - SEES ITS CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES AS OF DEC. 31, 2019 WILL ENABLE CO TO FUND
ITSELF INTO H1 OF 2021
Source text for Eikon: ID:nGNX7Kp1bd
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln